MYL: Viatris Inc. - Summary | Jitta

Viatris Inc.

NASDAQ:MYL

Notice
Stock data is unavailable or the company’s delisted.
Price
$15.86
Loss Chance
44.7%
4.21JITTA SCORE
63.45%Under Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (44)
Recent Business Performance (49)
Financial Strength (56)
Return to Shareholders (23)
Competitive Advantage (51)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Interest Coverage RatioGood
Revenue and EarningEarning decline from 2016-2019
Debt LevelHigh Long Term Debt
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.21
63.45%
3.03
208.13%
3.05
162.56%
Pharmaceuticals
5.41
29.01%
5.18
38.14%
6.36
51.23%
COMPANY DESCRIPTION
Viatris Inc., a healthcare company, manufactures and distributes various medicines for patients in the United States and internationally. Its portfolio comprises approximately 1,400 approved molecules across a range of therapeutic areas, including non-communicable and infectious diseases; complex generic and branded medicines; a portfolio of biosimilars; and various over-the-counter consumer products, as well as active pharmaceutical ingredients. The company is headquartered in Canonsburg, Pennsylvania.